This is in line with the fact that greater neocortical tau burden and less hippocampal tau in histopathologic9,26 and PET studies12,27-29 have been associated with atypical AD cases that exhibit early-onset cognitive and functional impairment and a more rapid clinical decline.30 Here, MAPT is linked to Alzheimer disease.